Pendulum Therapeutics
Pendulum Therapeutics believes therapies developed using evidence-based microbiome science and DNA sequencing can help heal the body from within. Armed with 13 patents and 42 pending, the company introduced its flagship product Pendulum Glucose Control, a medical probiotic, in 2020 and demonstrated its efficacy in lowering blood sugar spikes and reducing A1C in a published clinical trial. Founded in 2013 by a diverse team of scientists with deep microbiology, biochemistry, computational, and clinical expertise, Pendulum has raised $111 million to date from Meritech Capital, Sequoia Capital, True Ventures, Khosla Ventures, AME Cloud Ventures and Mayo Clinic among others. Pendulum Therapeutics is headquartered in San Francisco.
Tech Stack (38 technologies)
Frequently Asked Questions
What technologies does Pendulum Therapeutics use?+
Pendulum Therapeutics uses 38 technologies including Contentsquare, Google Analytics, Google Tag Manager.
What industry is Pendulum Therapeutics in?+
Pendulum Therapeutics operates in the Biotechnology industry.
Where is Pendulum Therapeutics based?+
Pendulum Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026